The Latest Headlines at The Cerbat Gem
Top Robotics Stocks To Consider – November 2nd
Teradyne, Ouster, MDA Space, PROCEPT BioRobotics, RoboStrategy, Richtech Robotics, and Serve Robotics are the seven Robotics stocks to watch today, according to MarketBeat’s stock screener tool. Robotics stocks are shares of... More of this article »
Contrasting Embraer-Empresa Brasileira de Aeronautica (EMBJ) and Its Peers
Embraer-Empresa Brasileira de Aeronautica (NYSE:EMBJ – Get Free Report) is one of 229 publicly-traded companies in the “Aerospace & Defense” industry, but how does it compare to its rivals? We will compare Embraer-Empresa... More of this article »
Brookfield Infrastructure Partners (NYSE:BIP) and MDU Resources Group (NYSE:MDU) Head-To-Head Comparison
Brookfield Infrastructure Partners (NYSE:BIP – Get Free Report) and MDU Resources Group (NYSE:MDU – Get Free Report) are both utilities companies, but which is the superior stock? We will contrast the two companies based... More of this article »
Mid Cap Stocks To Watch Now – November 2nd
ProShares UltraPro Short QQQ, American Airlines Group, IREN, Applied Optoelectronics, and AXT are the five Mid Cap stocks to watch today, according to MarketBeat’s stock screener tool. Mid-cap stocks are shares of companies... More of this article »
RedHill’s Crohn’s candidate keeps pace with its Phase 3 drug in lab tests (NASDAQ: RDHL)
What happened RedHill Biopharma Ltd. (NASDAQ: RDHL) said two sets of lab studies confirmed that RHB-204 kills MAP bacteria, comparably to RHB-104. RHB-204 is the company's reformulated Crohn's disease candidate. RHB-104 is... More of this article »
What Akebia Therapeutics (AKBA) Said on Its Q3 Earnings Call
Akebia Therapeutics (NASDAQ:AKBA) reported lower third-quarter revenue and a net loss as sales of its kidney disease drug Auryxia fell and inventory reductions limited revenue growth for its anemia treatment Vafseo, despite a sharp... More of this article »
What Rheinmetall (RHM) Said on Its Q3 Earnings Call
Rheinmetall (ETR:RHM) reported third-quarter sales growth of 36% but lowered its full-year outlook as a major German vehicle contract and acceptance tests for artillery ammunition are expected to slip into 2027. Sales rose to more... More of this article »
What Ethos Technologies Inc. Class A Common Stock (LIFE) Said on Its Q3 Earnings Call
Ethos Technologies Inc. Class A Common Stock (NASDAQ:LIFE) reported record third-quarter fiscal 2026 results, with revenue rising 151% year over year to $235 million as growth accelerated in both its direct-to-consumer and third-party... More of this article »
Reviewing Eversource Energy (NYSE:ES) & Genie Energy (NYSE:GNE)
Eversource Energy (NYSE:ES – Get Free Report) and Genie Energy (NYSE:GNE – Get Free Report) are both utilities companies, but which is the superior business? We will contrast the two businesses based on the strength of... More of this article »
MakeMyTrip (NASDAQ:MMYT) Stock: Insider Rajesh Magow Sells 20,000 Shares
MakeMyTrip Limited (NASDAQ:MMYT – Get Free Report) CEO Rajesh Magow sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 3rd. The shares were sold at an average price of $45.25,... More of this article »
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) Releases Earnings Results, Beats Expectations By $0.12 EPS
Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($0.40) earnings per share (EPS) for the quarter, topping the consensus estimate of... More of this article »
Compass Pathways (NASDAQ:CMPS) Posts Quarterly Earnings Results, Beats Estimates By $0.08 EPS
Compass Pathways (NASDAQ:CMPS – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported ($0.31) EPS for the quarter, topping the consensus estimate of ($0.39) by $0.08, Zacks reports. Here are... More of this article »
Allstate (NYSE:ALL) Sets New 1-Year High on Earnings Beat
The Allstate Corporation (NYSE:ALL – Get Free Report)’s share price reached a new 52-week high on Thursday following a better than expected earnings announcement. The stock traded as high as $280.23 and last traded at $278.3380,... More of this article »